One of Europe's oldest and largest insurers is heading for the exit. Aegon, the Dutch financial giant founded in 1844, has announced a sweeping corporate transformation that will see it abandon its Netherlands legal domicile in favour of the United States — a move that strips the European Union of one of its most prominent insurance players and raises uncomfortable questions about the bloc's regulatory appeal.
Announced at the company's Capital Markets Day in December 2025, the re-domiciliation is targeted for completion on January 1, 2028, at a cost of EUR 350 million. Upon completion, Aegon will rename itself Transamerica Inc., reflecting a business that has already shifted its centre of gravity decisively across the Atlantic — with roughly 70% of operations now based in the United States.
Solvency II Left Behind
The regulatory consequences are substantial. As a Dutch-domiciled insurer, Aegon currently operates under the EU's Solvency II framework — the pan-European capital adequacy and supervisory regime that governs insurers across the bloc. Relocating its legal seat to the US means Aegon will fall outside the direct jurisdiction of European insurance supervisors and the European Insurance and Occupational Pensions Authority (EIOPA).
The company has been navigating a complex multi-jurisdictional structure, previously maintaining ties to both the Netherlands and Bermuda, whose solvency regime holds European Commission equivalence status. That regulatory arbitrage becomes moot once Aegon plants its flag firmly in US soil and begins reporting under US GAAP from full-year 2027 results.
Shareholders will be asked to formally approve the move at an Extraordinary General Meeting in Q4 2026. Vereniging Aegon, the company's largest shareholder and custodian of its Dutch heritage, has already signalled it considers the US relocation positive and will review proposals constructively — a telling endorsement that removes a potential obstacle to the transition.
Amsterdam Loses a Pillar
The departure carries symbolic weight for the Netherlands and for Amsterdam's ambitions as a post-Brexit European financial centre. Aegon has maintained its Schiphol-area head office as a cornerstone of Dutch corporate identity. Losing that legal anchor — even if some operational presence remains — diminishes the country's profile in European financial services at a moment when cities including Amsterdam, Dublin and Paris have competed intensely to attract institutions displaced by Brexit.
The strategic logic from Aegon's perspective is clear. Transamerica, its US subsidiary, already generates the dominant share of revenues, with an operating result target of USD 1.4–1.6 billion for 2025 and a distribution network of over 92,000 independent agents through World Financial Group. The US retirement and life insurance market offers growth dynamics that dwarf those available in a mature, heavily regulated European landscape.
A Broader Warning Sign
Industry observers will note that Aegon's exit is not an isolated event but part of a pattern of European financial institutions recalibrating their regulatory exposure. The move prompts a pointed question for EU policymakers: is the cumulative burden of Solvency II, IFRS reporting requirements, and European supervisory architecture making the bloc less competitive as a domicile for globally-oriented insurers?
Aegon's own financials suggest the decision is driven by growth opportunity rather than distress — the company targets free cash flow of EUR 0.8 billion per year, growing at 5% annually, and has launched a EUR 400 million share buyback programme for 2026. But the direction of travel is unmistakable. For European regulators, the departure of a 180-year-old Dutch institution in favour of US jurisdiction is a signal that deserves serious scrutiny.
A strategic review of Aegon's UK operations is also underway, with divestment among the options being evaluated — suggesting further retrenchment from European exposure may follow the headline move across the Atlantic.